199 related articles for article (PubMed ID: 33780653)
1. Bronchopulmonary Dysplasia and Pulmonary Hypertension. The Role of Smooth Muscle
Raffay TM; Bonilla-Fernandez K; Jafri A; Sopi RB; Smith LA; Cui F; O'Reilly M; Zhang R; Hodges CA; MacFarlane PM; Deutsch G; Martin RJ; Gaston B
Am J Respir Cell Mol Biol; 2021 Jul; 65(1):70-80. PubMed ID: 33780653
[TBL] [Abstract][Full Text] [Related]
2. Tracheomalacia in bronchopulmonary dysplasia: Trachealis hyper-relaxant responses to S-nitrosoglutathione in a hyperoxic murine model.
Einisman HJ; Gaston B; Wijers C; Smith LA; Lewis TH; Lewis SJ; Raffay TM
Pediatr Pulmonol; 2019 Dec; 54(12):1989-1996. PubMed ID: 31486289
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of β-catenin signaling improves alveolarization and reduces pulmonary hypertension in experimental bronchopulmonary dysplasia.
Alapati D; Rong M; Chen S; Hehre D; Hummler SC; Wu S
Am J Respir Cell Mol Biol; 2014 Jul; 51(1):104-13. PubMed ID: 24484510
[TBL] [Abstract][Full Text] [Related]
4. Altered vasoreactivity in neonatal rats with pulmonary hypertension associated with bronchopulmonary dysplasia: Implication of both eNOS phosphorylation and calcium signaling.
Dumas de la Roque E; Smeralda G; Quignard JF; Freund-Michel V; Courtois A; Marthan R; Muller B; Guibert C; Dubois M
PLoS One; 2017; 12(2):e0173044. PubMed ID: 28235094
[TBL] [Abstract][Full Text] [Related]
5. S-Nitrosoglutathione Attenuates Airway Hyperresponsiveness in Murine Bronchopulmonary Dysplasia.
Raffay TM; Dylag AM; Di Fiore JM; Smith LA; Einisman HJ; Li Y; Lakner MM; Khalil AM; MacFarlane PM; Martin RJ; Gaston B
Mol Pharmacol; 2016 Oct; 90(4):418-26. PubMed ID: 27484068
[TBL] [Abstract][Full Text] [Related]
6. Tie-2 Cre-Mediated Deficiency of Extracellular Signal-Regulated Kinase 2 Potentiates Experimental Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension in Neonatal Mice.
Menon RT; Shrestha AK; Barrios R; Reynolds C; Shivanna B
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32244398
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic assessment of pulmonary hypertension using high-resolution echocardiography is feasible in neonatal mice with experimental bronchopulmonary dysplasia and pulmonary hypertension: a step toward preventing chronic obstructive pulmonary disease.
Reynolds CL; Zhang S; Shrestha AK; Barrios R; Shivanna B
Int J Chron Obstruct Pulmon Dis; 2016; 11():1597-605. PubMed ID: 27478373
[TBL] [Abstract][Full Text] [Related]
8. Lack of EC-SOD worsens alveolar and vascular development in a neonatal mouse model of bleomycin-induced bronchopulmonary dysplasia and pulmonary hypertension.
Delaney C; Wright RH; Tang JR; Woods C; Villegas L; Sherlock L; Savani RC; Abman SH; Nozik-Grayck E
Pediatr Res; 2015 Dec; 78(6):634-40. PubMed ID: 26322414
[TBL] [Abstract][Full Text] [Related]
9. Lung omics signatures in a bronchopulmonary dysplasia and pulmonary hypertension-like murine model.
Shrestha AK; Gopal VYN; Menon RT; Hagan JL; Huang S; Shivanna B
Am J Physiol Lung Cell Mol Physiol; 2018 Nov; 315(5):L734-L741. PubMed ID: 30047283
[TBL] [Abstract][Full Text] [Related]
10. Endothelial to mesenchymal transition during neonatal hyperoxia-induced pulmonary hypertension.
Gong J; Feng Z; Peterson AL; Carr JF; Vang A; Braza J; Choudhary G; Dennery PA; Yao H
J Pathol; 2020 Dec; 252(4):411-422. PubMed ID: 32815166
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-1 Receptor Antagonist Protects Newborn Mice Against Pulmonary Hypertension.
Bui CB; Kolodziej M; Lamanna E; Elgass K; Sehgal A; Rudloff I; Schwenke DO; Tsuchimochi H; Kroon MAGM; Cho SX; Maksimenko A; Cholewa M; Berger PJ; Young MJ; Bourke JE; Pearson JT; Nold MF; Nold-Petry CA
Front Immunol; 2019; 10():1480. PubMed ID: 31354700
[TBL] [Abstract][Full Text] [Related]
12. Airway Remodeling and Hyperreactivity in a Model of Bronchopulmonary Dysplasia and Their Modulation by IL-1 Receptor Antagonist.
Royce SG; Nold MF; Bui C; Donovan C; Lam M; Lamanna E; Rudloff I; Bourke JE; Nold-Petry CA
Am J Respir Cell Mol Biol; 2016 Dec; 55(6):858-868. PubMed ID: 27482635
[TBL] [Abstract][Full Text] [Related]
13. Chitin-Derived AVR-48 Prevents Experimental Bronchopulmonary Dysplasia (BPD) and BPD-Associated Pulmonary Hypertension in Newborn Mice.
Das P; Acharya S; Prahaladan VM; Kumova OK; Malaeb S; Behera S; Agarwal B; Christensen DJ; Carey AJ; Bhandari V
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445253
[TBL] [Abstract][Full Text] [Related]
14. Impaired Autophagic Activity Contributes to the Pathogenesis of Bronchopulmonary Dysplasia. Evidence from Murine and Baboon Models.
Zhang L; Soni S; Hekimoglu E; Berkelhamer S; Çataltepe S
Am J Respir Cell Mol Biol; 2020 Sep; 63(3):338-348. PubMed ID: 32374619
[TBL] [Abstract][Full Text] [Related]
15. Early gestational mesenchymal stem cell secretome attenuates experimental bronchopulmonary dysplasia in part via exosome-associated factor TSG-6.
Chaubey S; Thueson S; Ponnalagu D; Alam MA; Gheorghe CP; Aghai Z; Singh H; Bhandari V
Stem Cell Res Ther; 2018 Jun; 9(1):173. PubMed ID: 29941022
[TBL] [Abstract][Full Text] [Related]
16. Serotonin-deficient neonatal mice are not protected against the development of experimental bronchopulmonary dysplasia or pulmonary hypertension.
Roberts DS; Sherlock LG; Posey JN; Archambault JL; Nozik ES; Delaney CA
Physiol Rep; 2022 Oct; 10(19):e15482. PubMed ID: 36200294
[TBL] [Abstract][Full Text] [Related]
17. Animal models of bronchopulmonary dysplasia. The term mouse models.
Berger J; Bhandari V
Am J Physiol Lung Cell Mol Physiol; 2014 Dec; 307(12):L936-47. PubMed ID: 25305249
[TBL] [Abstract][Full Text] [Related]
18. Aberrant cGMP signaling persists during recovery in mice with oxygen-induced pulmonary hypertension.
Perez M; Lee KJ; Cardona HJ; Taylor JM; Robbins ME; Waypa GB; Berkelhamer SK; Farrow KN
PLoS One; 2017; 12(8):e0180957. PubMed ID: 28792962
[TBL] [Abstract][Full Text] [Related]
19. Blockade of JAK2 protects mice against hypoxia-induced pulmonary arterial hypertension by repressing pulmonary arterial smooth muscle cell proliferation.
Zhang L; Wang Y; Wu G; Rao L; Wei Y; Yue H; Yuan T; Yang P; Xiong F; Zhang S; Zhou Q; Chen Z; Li J; Mo BW; Zhang H; Xiong W; Wang CY
Cell Prolif; 2020 Feb; 53(2):e12742. PubMed ID: 31943454
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary vascular disease is evident in gene regulation of experimental bronchopulmonary dysplasia.
Revhaug C; Zasada M; Rognlien AGW; Günther CC; Grabowska A; Książek T; Madetko-Talowska A; Szewczyk K; Bik-Multanowski M; Kwinta P; Pietrzyk JJ; Baumbusch LO; Saugstad OD
J Matern Fetal Neonatal Med; 2020 Jun; 33(12):2122-2130. PubMed ID: 30428746
[No Abstract] [Full Text] [Related]
[Next] [New Search]
